Literature DB >> 29733431

Adverse Drug Reactions Reported by Healthcare Professionals: Reaction Characteristics and Time to Reporting.

Ar Kar Aung1,2,3, Mei Jie Tang1,4, Nikki Rae Adler3, Sara Lee de Menezes3, Michelle Sue Yen Goh5, Hui Wen Tee1, Jason Anthony Trubiano6,7, Robert Puy8, Celia Mary Zubrinich8, Linda Velta Graudins9,10.   

Abstract

We describe adverse drug reaction (ADR) reporting characteristics and factors contributing to length of time to report by healthcare professionals. This is a retrospective study of voluntary reports to an Australian healthcare ADR Review Committee over a 2-year period (2015-2016). Descriptive and univariate models were used for outcomes, employing standardized ADR definitions. Hospital pharmacists reported 84.8% of the 555 ADRs: 70.3% were hospital onset reactions, and 71.7% were at least of moderate severity. Immunologically mediated reactions were most commonly reported (409, 73.7%). The median time to submit an ADR report was 3 (interquartile range 1-10) days. Longer median times to reporting were associated with multiple implicated agents and delayed hypersensitivity reactions, especially severe cutaneous adverse reactions. A total of 650 medications were implicated that involved multiple agents in 165/555 (29.7%) reports. Antimicrobials were the most commonly implicated agents. Immunologically mediated reactions were most commonly associated with antimicrobials and radiocontrast agents (P < .0001, odds ratio [OR] 3.6, 95%CI 2.4-5.5, and P = .04, OR 4.2, 95%CI 1.2-18.2, respectively). Opioids and psychoactive medications were more commonly implicated in nonimmunological reported ADRs (P = .0002, OR 3.9, 95%CI 1.9-7.9, and P < .0001, OR 11.4, 95%CI 4.6-27.8, respectively). Due to the predominant reporting of immunologically mediated reactions, a targeted education program is being planned to improve identification and accuracy of ADR reports, with the overall aim of improved management to ensure quality service provision and patient safety.
© 2018, The American College of Clinical Pharmacology.

Entities:  

Keywords:  Adverse drug reactions; hypersensitivity; medication safety; pharmacoepidemiology; pharmacovigilance

Mesh:

Year:  2018        PMID: 29733431     DOI: 10.1002/jcph.1148

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  3 in total

1.  Headache as an Adverse Reaction to the Use of Medication in the Elderly: A Pharmacovigilance Study.

Authors:  Cristina Monteiro; Beatriz Dias; Maria Vaz-Patto
Journal:  Int J Environ Res Public Health       Date:  2021-03-07       Impact factor: 3.390

Review 2.  Adverse drug reaction management in hospital settings: review on practice variations, quality indicators and education focus.

Authors:  Ar Kar Aung; Steven Walker; Yin Li Khu; Mei Jie Tang; Jennifer I Lee; Linda Velta Graudins
Journal:  Eur J Clin Pharmacol       Date:  2022-02-16       Impact factor: 2.953

3.  Reporting Rates of Opioid-Related Adverse Events Since 1965 in Canada: A Descriptive Retrospective Study.

Authors:  Maude Lavallée; Carolina Galli da Silveira; Samuel Akinola; Julie Méthot; Marie-Eve Piché; Anick Bérard; Magalie Thibault; Jennifer Midiani Gonella; Fernanda Raphael Escobar Gimenes; Jacinthe Leclerc
Journal:  Drugs Real World Outcomes       Date:  2021-09-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.